The effects of healthy food derived from corn leaf dietary fiber on body weight and body mass index change in overweight volunteers

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210806003

Enrollment

Registered

2021-08-06

Start date

2022-02-14

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy conditions Dietary fiber purple waxy corn corn leaf body weight body mass index BMI overweight

Interventions

Subjects are received the placebo product which has the same color and smells look like jelly mixed with dietary fiber from corn leaf ,Subjects are received jelly mixed with dietary fiber from corn le

Placebo Comparator Other,Experimental Dietary Supplement,Experimental Dietary Supplement

Placebo, Jelly mixed with dietary fiber from corn leaf 5 gram/day,Jelly mixed with dietary fiber from corn leaf 10 gram/day

Eligibility

Sex/Gender

All

Age

35 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 35-60 years old 2.Body Mass Index (BMI) more than 23 kg/m2

Exclusion criteria

Exclusion criteria: 1. Volunteers who have been diagnosed with one of the following; cardiovascular diseases, respiratory diseases, neuropsychological diseases, liver disease (AST more than 64 U/L, ALT more than 50 U/L), Kidney disease (estimate GFR less than 90 ml/min), autoimmune disease, hematological disorder, cancer, and hypertension 2. Fasting Blood Sugar (FBS) after fasts for 8 hours more than 100 mg/dL 3. Volunteers who use supplements or any drug that affect the body weight, glucose, and lipid level before trial 4. Smoking more than 10 pieces/ day 5. Drinking alcohol more than 5 times/ day 6. Pregnancy or lactating women

Design outcomes

Primary

Measure	Time frame
Body weight and body mass index 6 weeks Equipment	—

Secondary

Measure	Time frame
The changes of hematological and clinical chemistry parameters 6 weeks Laboratory,Urinalysis 6 weeks Laboratory,HOMA-IR, AI, and Insulin 6 weeks Laboratory,Angiotensin converting enzyme (ACE) 6 weeks Elisa method,Advanced glycation end products (AGEs) 6 weeks Elisa method,The changes of electrocardiogram 6 weeks Electrocardiography,Stool examination (PH, Total lactic acid, Bifidobacterial, Short chain fatty acid) 6 weeks Laboratory,Safety evaluation 6 weeks Questionnaire	—

Measure

Time frame

The changes of hematological and clinical chemistry parameters 6 weeks Laboratory,Urinalysis 6 weeks Laboratory,HOMA-IR, AI, and Insulin 6 weeks Laboratory,Angiotensin converting enzyme (ACE) 6 weeks Elisa method,Advanced glycation end products (AGEs) 6 weeks Elisa method,The changes of electrocardiogram 6 weeks Electrocardiography,Stool examination (PH, Total lactic acid, Bifidobacterial, Short chain fatty acid) 6 weeks Laboratory,Safety evaluation 6 weeks Questionnaire

—

Countries

Thailand

Contacts

Public ContactWipawee Thukhammee

Khon Kaen University

wipath@kku.ac.th0850016805

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026